Zetia and Cancer
Links shared publicly online about this topic
Follow-Up to the August 2008 Early Communication About an Ongoing Safety Review of Ezetimibe/Simvastatin (marketed as Vytorin), Simvastatin (marketed as Zocor) and Ezetimibe (marketed as Zetia) - FDA Investigates a Report from the SEAS Trial
fda.gov — “In august 2008, the u.s. food and drug administration (fda) issued an early communication describing a possible association between the use of vytorin – a combination of simvastatin (zocor) and ezetimibe (zetia) – and an increased risk of cancer and cancer-related death compared to placebo.” View full resource at fda.gov
Most Recently Shared on December 22, 2009 at 4:31 pm By:
RT @FDA_Drug_Info: Follow-Up to the Aug. 2008 Early Communication on Vytorin, Zetia, Zocor and the SEAS Trial. http://bit.ly/FU_SEAS
Ezetimibe and cancer
theheart.org — “Over a four-year period, the rates of cancer-associated adverse events and the proportion of all reported adverse events related to cancer were less than event rates observed with other potent cholesterol-lowering medications.” View full resource at theheart.org
Most Recently Shared on March 25, 2009 at 10:01 pm By:
FDA postmarketing surveillance data show no cancer risk with ezetimibe http://tinyurl.com/cazb7s
Ezetimibe and cancer risk
theheart.org — “Based on current information, the agency said an association between ezetimibe and cancer risk or cancer-related mortality is not likely, although this association can't be definitively ruled out yet.” View full resource at theheart.org
Most Recently Shared on December 22, 2009 at 9:39 pm By:
FDA says cancer risk with ezetimibe is unlikely http://bit.ly/7KabXf #heartwire
Is Vytorin Cancer Risk Real?
webmd.com — “Is there really a link between the cholesterol-lowering drug Vytorin and cancer? This WebMD FAQ tells you what is and isn't known.” View full resource at webmd.com
Most Recently Shared on August 23, 2008 at 12:22 am By:
WebMD Health News Is Vytorin Cancer Risk Real?: Is there really a link between the ch.. http://tinyurl.com/6efkqt
FDA to Explore Possible Vytorin-Cancer Link
webmd.com — “The FDA is investigating a report from the SEAS trial of a possible association between use of the drug Vytorin and increased cancer risk.” View full resource at webmd.com
Most Recently Shared on August 22, 2008 at 2:22 am By:
WebMD Health News FDA to Explore Possible Vytorin-Cancer Link: The FDA is investigati.. http://tinyurl.com/6nqy3r
FDA: Vytorin Unlikely to Up Cancer Risk
webmd.com — “The fda says a connection between the cholesterol-lowering drug vytorin and cancer risk is unlikely, but cannot be ruled out.” View full resource at webmd.com
Most Recently Shared on December 23, 2009 at 12:31 am By:
FDA: Vytorin Unlikely to Up Cancer Risk: The FDA has backed off a 2008 statement describing a possible link between... http://bit.ly/4PbWLG
Sensationalizing research
theheart.org — “A new editorial addresses the current challenges of clinical research, particularly the need to avoid public, media, and clinical sensationalism regarding new drugs and devices. With big drugs coming to market affecting a large number of patients, clinicians need to properly put the risks and benefits into context and to trust the structures already in place to manage adverse-event signals, say the editorialists.” View full resource at theheart.org
Most Recently Shared on April 19, 2010 at 12:57 pm By:
This drug kills patients! Avoiding sensationalism in clinical trials: A new editorial addresses the current challe... http://bit.ly/aEswRr
The Top 3 resources shared on this topic. More resources.
Key stats and trends about this topic
Featuring the top 3 experts for this topic
-
eyeonfda
Author of the blog Eye on FDA - www.eyeonfda.com
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
-
Shelley Wood
Managing editor for heartwire on theheart.org--the most authoritative, balanced, and insightful cardiovascular disease news online. http://is.gd/nHJ4
Advertisement

